Clinical Trial Update: Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating the safety, tolerability, and pharmacokinetics of HE3286 in adults with active mild-to-moderate ulcerative colit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• HE3286

Snippet

Sponsor: Harbor Therapeutics | Conditions: Ulcerative Colitis | Phase 1, Phase 2 | Status: COMPLETED